Companies / Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc.
Nasdaq: PVLACIK 1583648WAYNE, PA
Financials · FY2023
Ownership
14.4M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.63% | 235,428 |
| Institutions | 78.24% | 11,273,777 |
| Public float | 20.12% | 2,899,202 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Jenkins George MDirector | 1.30% | 187,616 |
Heron Elaine JDirector | 0.33% | 47,812 |
Goin KathleenChief Operating Officer | 0.00% | 0 |
Davis Todd CDirector | — | — |
Kaupinen WesCEOPresident and CEO · Director · 10% owner | — | — |
Kiritsy Christopher PDirector | — | — |
Kline Ashley HartmannChief Commercial Officer | — | — |
Korenberg Matthew ECFO, Treasurer | — | — |
Martini Jeffrey SChief Scientific Officer | — | — |
Institutional holders 156
View all →| Holder | Value | % of shares |
|---|---|---|
| $140.34M | 6.37% | |
| $119.79M | 6.67% | |
| $99.82M | 4.53% | |
| $93.41M | 6.19% | |
| $75.61M | 5.01% | |
| $74.23M | 4.92% | |
| $58.68M | 3.89% | |
| $53.98M | 3.01% | |
| $40.76M | 2.70% | |
| $40.56M | 2.69% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Jenkins George M Director | Buy | Common Stock | $500.0K | +4K +2.18% | 187,171 1.30% of shares | high |
| Jan 21, 2026 | Goin Kathleen Executive | Sell | Common Stock | $367.2K | -4K -100.00% | 0 0.00% of shares | medium |
| Feb 27, 2026 | Heron Elaine J Director | Buy | Common Stock | $300.0K | +2K +5.28% | 47,812 0.33% of shares | medium |
| Mar 18, 2026 | Goin Kathleen Executive | Sell | Common Stock | $266.6K | -2K -52.72% | 2,034 0.01% of shares | medium |
| Feb 18, 2026 | Goin Kathleen Executive | Sell | Common Stock | $239.5K | -3K -70.34% | 1,276 <0.01% of shares | medium |
| Mar 18, 2026 | Goin Kathleen Executive | Sell | Common Stock | $204.8K | -2K -85.05% | 304 <0.01% of shares | medium |
| Feb 18, 2026 | Goin Kathleen Executive | Sell | Common Stock | $102.0K | -1K -100.00% | 0 0.00% of shares | medium |
| Jan 21, 2026 | Goin Kathleen Executive | Sell | Common Stock | $52.8K | -553 -12.85% | 3,749 0.03% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | Passive13G/A | — |
| Biotechnology Value Fund L P | Passive13G/A | — |
| First Light Asset Management, LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PVLA | Common Stock | 697947109 |